Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2020-12-11
Date Granted : 2008-10-14
Brand Name : XARELTO
Patent Number : 2396561
Filing Date : 2000-12-11
Strength per Unit : 10 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2020-12-11
Date Granted : 2008-10-14
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2020-12-11
Date Granted : 2008-10-14
Brand Name : XARELTO
Patent Number : 2396561
Filing Date : 2000-12-11
Strength per Unit : 15 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2020-12-11
Date Granted : 2008-10-14
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2020-12-11
Date Granted : 2008-10-14
Brand Name : XARELTO
Patent Number : 2396561
Filing Date : 2000-12-11
Strength per Unit : 20 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2020-12-11
Date Granted : 2008-10-14
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2026-09-22
Date Granted : 2014-01-07
Brand Name : XARELTO
Patent Number : 2624310
Filing Date : 2006-09-22
Strength per Unit : 10 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-09-22
Date Granted : 2014-01-07
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2024-11-13
Date Granted : 2012-01-24
Brand Name : XARELTO
Patent Number : 2547113
Filing Date : 2004-11-13
Strength per Unit : 10 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2024-11-13
Date Granted : 2012-01-24
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2026-09-22
Date Granted : 2014-10-21
Brand Name : XARELTO
Patent Number : 2823159
Filing Date : 2006-09-22
Strength per Unit : 10 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-09-22
Date Granted : 2014-10-21
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2026-09-22
Date Granted : 2014-01-07
Brand Name : XARELTO
Patent Number : 2624310
Filing Date : 2006-09-22
Strength per Unit : 15 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-09-22
Date Granted : 2014-01-07
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2024-11-13
Date Granted : 2012-01-24
Brand Name : XARELTO
Patent Number : 2547113
Filing Date : 2004-11-13
Strength per Unit : 15 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2024-11-13
Date Granted : 2012-01-24
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2026-09-22
Date Granted : 2014-10-21
Brand Name : XARELTO
Patent Number : 2823159
Filing Date : 2006-09-22
Strength per Unit : 15 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-09-22
Date Granted : 2014-10-21
Bayer AG manufactures innovative APIs and pharmaceutical formulations across diverse therapeutic areas.
Patent Expiration Date : 2026-09-22
Date Granted : 2014-01-07
Brand Name : XARELTO
Patent Number : 2624310
Filing Date : 2006-09-22
Strength per Unit : 20 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-09-22
Date Granted : 2014-01-07
